← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
  1. Home
  2. Financial Ratios

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.
US Stock Screener
HomeScreensNewsWatchlist
...
  1. Home
  2. Financial Ratios
  3. Quarterly

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.
US Stock Screener
HomeScreensNewsWatchlist
...
  1. Home
  2. CLBT
  3. Financial Ratios
  4. Quarterly
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Cellebrite DI Ltd. (CLBT) Quarterly Financial Ratios

Last 22 quarters of trend data · Technology · Software - Infrastructure

← View 30-Year Annual Ratios

Valuation Multiples

Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.

Cellebrite DI Ltd.'s quarterly P/E stands at 56.3x, down 20.3% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 37.2% YoY to 44.8x, reflecting multiple compression or accelerating EBITDA.

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
P/E Ratio →43.0356.3457.3351.1569.3970.70————60.14——
—-20.3%————————+697.8%——
P/S Ratio6.868.809.188.7911.2612.498.226.216.094.534.644.423.98
—-29.6%+11.6%+41.6%+85.0%+176.0%+77.1%+40.6%+52.8%+59.4%+75.8%+12.2%-20.8%
P/B Ratio6.889.3610.349.7513.3316.2211.78——49.2241.2177.1628.83
—-42.3%-12.3%——-67.1%-71.4%——+332.5%+223.6%+88.4%—
P/FCF20.3413.6838.6334.3765.3222.1022.0648.8768.8310.8313.9121.5024.86
—-38.1%+75.1%-29.7%-5.1%+104.1%+58.6%+127.3%+176.9%+67.8%———
EV / EBITDA40.3344.7850.3356.2579.9471.3738.4137.8843.4221.4122.6843.72101.69
—-37.2%+31.0%+48.5%+84.1%+233.3%+69.4%-13.4%-57.3%+35.9%-83.5%—-94.0%
EV / EBIT47.5253.2744.9566.3697.0883.7543.5945.6956.0025.1426.6868.011931.35
—-36.4%+3.1%+45.2%+73.4%+233.1%+63.4%-32.8%-97.1%+26.6%———

Profitability

Quarterly margins and returns. Watch for margin compression across consecutive quarters.

Cellebrite DI Ltd.'s operating margin was 16.2% in Q4 2025, up 1.1 pp QoQ and up 1.7 pp YoY. This marks the 4th consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 13.8% lags the current quarter, suggesting the recent improvement is above-trend.

Margins

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Gross Margin84.2%84.7%83.9%84.4%83.7%83.8%85.5%83.0%85.2%84.0%84.7%83.0%82.6%
—+1.0%-1.9%+1.7%-1.7%-0.1%+1.0%+0.0%+3.2%+0.4%+6.2%+5.0%+0.2%
Operating Margin14.0%16.2%15.1%12.7%11.4%14.4%18.2%13.0%10.3%16.1%16.0%6.0%0.2%
—+12.0%-17.2%-2.4%+10.5%-10.6%+13.6%+116.4%+5307.2%+23.4%+1157.8%+167.4%+106.1%
Net Margin16.5%16.5%16.0%17.2%16.2%17.7%-193.8%-24.9%-79.7%-15.7%7.7%-42.2%-57.0%
—-6.6%+108.3%+169.1%+120.3%+212.2%-2609.9%+41.0%-39.8%-264.7%-77.9%-179.5%-164.1%

Return on Capital

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
ROE19.1%4.6%4.7%5.0%5.0%6.1%-160.4%—-1901.7%-40.6%23.4%-113.7%-71.7%
—-24.9%+102.9%—+100.3%+115.0%-784.9%—-2551.4%-482.4%-61.0%-120.3%—
ROA9.6%2.4%2.5%2.6%2.5%2.9%-34.9%-4.4%-13.4%-2.9%1.4%-7.7%-10.0%
—-17.9%+107.1%+159.3%+118.5%+200.7%-2525.7%+43.1%-35.1%-254.9%-80.6%-175.5%-159.6%
ROIC18.5%5.5%6.5%4.0%4.2%7.2%75.2%——————
—-23.6%-91.4%——————————

Leverage & Debt

Quarterly solvency trend — watch for debt spikes or covenant pressure.

Cellebrite DI Ltd.'s Debt/EBITDA ratio is 0.9x, down from 1.0x last quarter — comfortably within a safe range. The current ratio has weakened 18.9% YoY to 1.56x, tightening the short-term liquidity position. Debt/Equity has declined for 3 consecutive quarters, reflecting a deleveraging trend.

MetricTTMQ4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23Q1 '23
Debt / Equity0.050.050.050.050.030.030.04——0.410.320.770.38
—+43.4%+16.4%——-92.1%-87.0%——+98.7%———
Debt / EBITDA0.290.920.991.310.710.590.560.781.090.800.761.895.74
—+54.1%+77.7%+69.4%-34.5%-25.9%-26.6%-59.0%-81.1%-36.3%———
Current Ratio1.561.562.111.961.821.921.841.751.591.661.651.651.52
—-18.9%+14.8%+11.8%+14.4%+15.5%+11.3%+6.0%+4.9%+16.8%+19.3%+22.1%+3.3%
Quick Ratio1.541.542.081.921.791.891.801.711.551.621.601.601.46
—-18.7%+15.5%+12.5%+15.3%+16.4%+12.6%+7.2%+6.2%+18.1%+20.0%+22.4%+2.8%
Interest Coverage——————0.090.360.12—2.030.130.00
—————————————

Download Financial Ratios Data

Includes 30+ ratios · 22 years · Updated daily

See CLBT's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is CLBT Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare with Peers

Compare performance and metrics against top competitors.

Start Comparison

Frequently Asked Questions

What is Cellebrite DI Ltd.'s quarterly P/E ratio trend?

Cellebrite DI Ltd.'s current P/E is 43.0x. The average P/E over the last 4 quarters is 58.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.

How do Cellebrite DI Ltd.'s margins change by quarter?

Cellebrite DI Ltd.'s current operating margin is 14.0%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.

Why look at CLBT quarterly ratios instead of annual?

Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cellebrite DI Ltd.'s business trajectory between earnings reports.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.